3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
42
INDUSTRY
18
OTHER_GOV
3
UNKNOWN
1
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Neoplasm Metastasis
1
Interventions
Paclitaxel
20
Capecitabine
18
S 1 (combination)
17
Cisplatin
15
Oxaliplatin
11
Radiotherapy, Intensity-Modulated
9
apatinib
8
Epirubicin
8
Docetaxel
8
Carboplatin
8
Radiotherapy
7
Irinotecan
7
titanium silicide
6
sintilimab
6
pyrotinib
6
nimotuzumab
6
anlotinib
6
Drug Therapy
6
Albumin-Bound Paclitaxel
6
130-nm albumin-bound paclitaxel
6
nedaplatin
5
camrelizumab
5
Temozolomide
5
Etoposide
5
Bevacizumab
5
nabiximols
4
Vinorelbine
4
Trastuzumab
4
Radiation Dose Hypofractionation
4
Pemetrexed
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
UNKNOWN
×
Interventional
×
Platinum Compounds
×
Clear all
NCT05136768
2021-11-29
LM-HNSCC
ChineseAMS
Phase 2
Unknown
50 enrolled